Should sunitinib still be used in the treatment of metstatic kidney cancer?
Michael Atkins • 8 Sep 2017
Promising results for axitinib and pembrolizumab in advanced renal cell cancer
Michael Atkins • 8 Feb 2018
Subgroup analyses in the CLEAR study of lenvatinib plus pembrolizumab versus sunitinib in RCC
Viktor Grünwald • 7 Jun 2021